HomeRIGL • NASDAQ
Rigel Pharmaceuticals Inc
$18.61
0.85%
-0.16 Today
After Hours:
$19.72
(5.96%)+1.11
Closed: May 12, 5:20:00 PM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
020M40M
Revenue
Net Income
Revenue
Net income
(USD)Mar 2025Y/Y change
Revenue
53.33M80.58%
Operating expense
27.72M-2.58%
Net income
11.45M238.79%
Net profit margin
21.46176.86%
Earnings per share
0.63226.00%
EBITDA
13.38M303.73%
Effective tax rate
0.56%
050M100M150M
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD)Mar 2025Y/Y change
Cash and short-term investments
77.10M55.60%
Total assets
175.97M39.09%
Total liabilities
157.41M-0.50%
Total equity
18.57M
Shares outstanding
17.87M
Price to book
18.05
Return on assets
18.79%
Return on capital
28.66%
-10M010M
Net Change in Cash
Net change in cash
(USD)Mar 2025Y/Y change
Net income
11.45M238.79%
Cash from operations
-893.00K82.19%
Cash from investing
-10.55M-3,471.25%
Cash from financing
484.00K119.27%
Net change in cash
-10.96M-51.98%
Free cash flow
-5.31M-137.23%
StockUS listed securityUS headquartered
Previous close
$18.77
Day range
$18.44 - $19.74
Year range
$7.48 - $29.82
Market cap
332.61M USD
Avg Volume
221.74K
P/E ratio
8.97
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1996
Website
Employees
163
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Main menu
Google apps